Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME (USD $)	COMMON STOCK [Member]	ADDITIONAL PAID-IN CAPITAL [Member]	DEFICIT [Member]	STOCK TO BE REFUND [Member]	NON CONTROLLING INTEREST [Member]	Total
Beginning Balance at Oct. 31, 2013	$ 16,432	$ 7,140,148	$ (5,057,677)			$ 2,098,903
Beginning Balance (Shares) at Oct. 31, 2013	16,431,452
Shares Cancelled				(35,200)		(35,200)
Shares issued for PP @ $0.06	500	29,500				30,000lxrp_SharesIssuedForPPSix
Shares issued for PP @ $0.06 (Shares)	500,000
Shares issued for services @ $0.10	1,500	178,500				180,000lxrp_SharesIssuedForServicesOneZero
Shares issued for services @ $0.10 (Shares)	1,500,000
Shares issued for services @ $0.40	150	62,850				63,000lxrp_SharesIssuedForServicesFourZero
Shares issued for services @ $0.40 (Shares)	150,000
Shares issued for services @ $0.60	21	12,479				12,500lxrp_SharesIssuedForServicesSixZero
Shares issued for services @ $0.60 (Shares)	20,833
Shares issued for PP @ $0.12	11,420	1,246,735				1,258,155lxrp_SharesIssuedForPPOneTwo
Shares issued for PP @ $0.12 (Shares)	11,419,999
Shares issued for option exercise @ $0.35	50	17,450				17,500
Shares issued for option exercise @ $0.35 (Shares)	50,000
Stock Options issued @ $0.60		26,112				26,112lxrp_StockOptionsIssuedSixZero
Shares issued for debt conversion @$0.35	552	192,781				193,333
Shares issued for debt conversion @$0.35 (Shares)	552,380
Shares issued per LOI @ $0.40	555	221,445				222,000lxrp_SharesIssuedPerLOIFourZero
Shares issued per LOI @ $0.40 (Shares)	555,000
Shares issued per agreement @ $0.39	110	42,790				42,900lxrp_SharesIssuedPerAgreementThreeNine
Shares issued per agreement @ $0.39 (Shares)	110,000
Shares issued per agreement @ $0.32	550	175,450				176,000lxrp_SharesIssuedPerAgreementThreeTwo
Shares issued per agreement @ $0.32 (Shares)	550,000
Stock Options issued @ $0.25		183,432				183,432lxrp_StockOptionsIssuedTwoFive
Shares issued for option exercise @ $0.10	50	4,950				5,000
Shares issued for option exercise @ $0.10 (Shares)	50,000
Shares issued per agreement @ $0.30	55	16,445				16,500lxrp_SharesIssuedPerAgreementThreeZero
Shares issued per agreement @ $0.30 (Shares)	55,000
Shares issued per agreement @ $0.26	880	263,120				264,000lxrp_SharesIssuedPerAgreementTwoSix
Shares issued per agreement @ $0.26 (Shares)	880,000
Shares issued per LOI @ $0.30	92	27,408				27,500lxrp_SharesIssuedPerLOIThreeZero
Shares issued per LOI @ $0.30 (Shares)	91,662
Shares issued per agreement @ $0.16	82	13,043				13,125lxrp_SharesIssuedPerAgreementOneSix
Shares issued per agreement @ $0.16 (Shares)	82,031
Shares issued for PP @ $0.15	1,250	178,800				180,050lxrp_SharesIssuedForPPOneFive
Shares issued for PP @ $0.15 (Shares)	1,251,333
Comprehensive income (loss) for the period			(3,257,712)			(3,257,712)us-gaap_ComprehensiveIncomeNetOfTax
Ending Balance at Aug. 31, 2014	34,249	10,033,438	(8,315,389)	(35,200)		1,717,098
Ending Balance (Shares) at Aug. 31, 2014	34,249,690
Shares Cancelled	(110)	(35,090)		35,200
Shares Cancelled (Shares)	(110,000)
Shares issued for PP @ $0.15	305	45,475				45,780lxrp_SharesIssuedForPPOneFive
Shares issued for PP @ $0.15 (Shares)	305,200
Non-controlling Interest					27,442	27,442lxrp_InvestmentInVipova
Shares issued per agreement @$0.105	238	24,762				25,000
Shares issued per agreement @$0.105 (Shares)	238,094
Stock Options issued @ $0.11 and $0.10		144,199				144,199lxrp_StockOptionsIssuedOneOneAndOneZero
Comprehensive income (loss) for the period			(787,165)			(787,165)us-gaap_ComprehensiveIncomeNetOfTax
Ending Balance at Feb. 28, 2015	$ 34,682	$ 10,212,784	$ (9,102,554)		$ 27,442	$ 1,172,354
Ending Balance (Shares) at Feb. 28, 2015	34,682,984